Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 2002 Apr 1;363(Pt 1):157–165. doi: 10.1042/0264-6021:3630157

Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.

Anne-M Krogsdam 1, Curt A F Nielsen 1, Søren Neve 1, Dorte Holst 1, Torben Helledie 1, Bo Thomsen 1, Christian Bendixen 1, Susanne Mandrup 1, Karsten Kristiansen 1
PMCID: PMC1222462  PMID: 11903058

Abstract

The nuclear receptor corepressor (NCoR) was isolated as a peroxisome-proliferator-activated receptor (PPAR) delta interacting protein using the yeast two-hybrid system. NCoR interacted strongly with the ligand-binding domain of PPAR delta, whereas interactions with the ligand-binding domains of PPAR gamma and PPAR alpha were significantly weaker. PPAR-NCoR interactions were antagonized by ligands in the two-hybrid system, but were ligand-insensitive in in vitro pull-down assays. Interaction between PPAR delta and NCoR was unaffected by coexpression of retinoid X receptor (RXR) alpha. The PPAR delta-RXR alpha heterodimer bound to an acyl-CoA oxidase (ACO)-type peroxisome-proliferator response element recruited a glutathione S-transferase-NCoR fusion protein in a ligand-independent manner. Contrasting with most other nuclear receptors, PPAR delta was found to interact equally well with interaction domains I and II of NCoR. In transient transfection experiments, NCoR and the related silencing mediator for retinoid and thyroid hormone receptor (SMRT) were shown to exert a marked dose-dependent repression of ligand-induced PPAR delta-mediated transactivation; in addition, transactivation induced by the cAMP-elevating agent forskolin was efficiently reduced to basal levels by NCoR as well as SMRT coexpression. Our results suggest that the transactivation potential of liganded PPAR delta can be fine-tuned by interaction with NCoR and SMRT in a manner determined by the expression levels of corepressors and coactivators.

Full Text

The Full Text of this article is available as a PDF (284.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amri E. Z., Bonino F., Ailhaud G., Abumrad N. A., Grimaldi P. A. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem. 1995 Feb 3;270(5):2367–2371. doi: 10.1074/jbc.270.5.2367. [DOI] [PubMed] [Google Scholar]
  2. Bastie C., Holst D., Gaillard D., Jehl-Pietri C., Grimaldi P. A. Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts. J Biol Chem. 1999 Jul 30;274(31):21920–21925. doi: 10.1074/jbc.274.31.21920. [DOI] [PubMed] [Google Scholar]
  3. Bendixen C., Gangloff S., Rothstein R. A yeast mating-selection scheme for detection of protein-protein interactions. Nucleic Acids Res. 1994 May 11;22(9):1778–1779. doi: 10.1093/nar/22.9.1778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen J. D., Evans R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 1995 Oct 5;377(6548):454–457. doi: 10.1038/377454a0. [DOI] [PubMed] [Google Scholar]
  5. Crawford P. A., Dorn C., Sadovsky Y., Milbrandt J. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol. 1998 May;18(5):2949–2956. doi: 10.1128/mcb.18.5.2949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dowell P., Ishmael J. E., Avram D., Peterson V. J., Nevrivy D. J., Leid M. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein. J Biol Chem. 1999 May 28;274(22):15901–15907. doi: 10.1074/jbc.274.22.15901. [DOI] [PubMed] [Google Scholar]
  7. Gao X., Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun. 1991 Aug 30;179(1):280–285. doi: 10.1016/0006-291x(91)91366-k. [DOI] [PubMed] [Google Scholar]
  8. Glass C. K., Rosenfeld M. G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000 Jan 15;14(2):121–141. [PubMed] [Google Scholar]
  9. Gupta R. A., Tan J., Krause W. F., Geraci M. W., Willson T. M., Dey S. K., DuBois R. N. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13275–13280. doi: 10.1073/pnas.97.24.13275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gurnell M., Wentworth J. M., Agostini M., Adams M., Collingwood T. N., Provenzano C., Browne P. O., Rajanayagam O., Burris T. P., Schwabe J. W. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem. 2000 Feb 25;275(8):5754–5759. doi: 10.1074/jbc.275.8.5754. [DOI] [PubMed] [Google Scholar]
  11. Hansen J. B., Zhang H., Rasmussen T. H., Petersen R. K., Flindt E. N., Kristiansen K. Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J Biol Chem. 2000 Nov 7;276(5):3175–3182. doi: 10.1074/jbc.M005567200. [DOI] [PubMed] [Google Scholar]
  12. Henzel W. J., Billeci T. M., Stults J. T., Wong S. C., Grimley C., Watanabe C. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5011–5015. doi: 10.1073/pnas.90.11.5011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hu X., Lazar M. A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature. 1999 Nov 4;402(6757):93–96. doi: 10.1038/47069. [DOI] [PubMed] [Google Scholar]
  14. Hu X., Li Y., Lazar M. A. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Mol Cell Biol. 2001 Mar;21(5):1747–1758. doi: 10.1128/MCB.21.5.1747-1758.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hörlein A. J., När A. M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., Glass C. K. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 1995 Oct 5;377(6548):397–404. doi: 10.1038/377397a0. [DOI] [PubMed] [Google Scholar]
  16. Johnson B. A., Wilson E. M., Li Y., Moller D. E., Smith R. G., Zhou G. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation. J Mol Biol. 2000 Apr 28;298(2):187–194. doi: 10.1006/jmbi.2000.3636. [DOI] [PubMed] [Google Scholar]
  17. Juge-Aubry C., Pernin A., Favez T., Burger A. G., Wahli W., Meier C. A., Desvergne B. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region. J Biol Chem. 1997 Oct 3;272(40):25252–25259. doi: 10.1074/jbc.272.40.25252. [DOI] [PubMed] [Google Scholar]
  18. Klein E. S., Wang J. W., Khalifa B., Gavigan S. A., Chandraratna R. A. Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions. J Biol Chem. 2000 Jun 23;275(25):19401–19408. doi: 10.1074/jbc.M002472200. [DOI] [PubMed] [Google Scholar]
  19. Kliewer S. A., Forman B. M., Blumberg B., Ong E. S., Borgmeyer U., Mangelsdorf D. J., Umesono K., Evans R. M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7355–7359. doi: 10.1073/pnas.91.15.7355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992 Aug 27;358(6389):771–774. doi: 10.1038/358771a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kliewer S. A., Xu H. E., Lambert M. H., Willson T. M. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res. 2001;56:239–263. doi: 10.1210/rp.56.1.239. [DOI] [PubMed] [Google Scholar]
  22. Kodera Y., Takeyama K., Murayama A., Suzawa M., Masuhiro Y., Kato S. Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators. J Biol Chem. 2000 Oct 27;275(43):33201–33204. doi: 10.1074/jbc.C000517200. [DOI] [PubMed] [Google Scholar]
  23. Kurokawa R., Söderström M., Hörlein A., Halachmi S., Brown M., Rosenfeld M. G., Glass C. K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature. 1995 Oct 5;377(6548):451–454. doi: 10.1038/377451a0. [DOI] [PubMed] [Google Scholar]
  24. Lavinsky R. M., Jepsen K., Heinzel T., Torchia J., Mullen T. M., Schiff R., Del-Rio A. L., Ricote M., Ngo S., Gemsch J. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2920–2925. doi: 10.1073/pnas.95.6.2920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lazennec G., Canaple L., Saugy D., Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol. 2000 Dec;14(12):1962–1975. doi: 10.1210/mend.14.12.0575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lim H., Gupta R. A., Ma W. G., Paria B. C., Moller D. E., Morrow J. D., DuBois R. N., Trzaskos J. M., Dey S. K. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev. 1999 Jun 15;13(12):1561–1574. doi: 10.1101/gad.13.12.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mangelsdorf D. J., Borgmeyer U., Heyman R. A., Zhou J. Y., Ong E. S., Oro A. E., Kakizuka A., Evans R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992 Mar;6(3):329–344. doi: 10.1101/gad.6.3.329. [DOI] [PubMed] [Google Scholar]
  28. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. The nuclear receptor superfamily: the second decade. Cell. 1995 Dec 15;83(6):835–839. doi: 10.1016/0092-8674(95)90199-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Matsuura H., Adachi H., Smart R. C., Xu X., Arata J., Jetten A. M. Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol Cell Endocrinol. 1999 Jan 25;147(1-2):85–92. doi: 10.1016/s0303-7207(98)00214-7. [DOI] [PubMed] [Google Scholar]
  30. Nagy L., Kao H. Y., Love J. D., Li C., Banayo E., Gooch J. T., Krishna V., Chatterjee K., Evans R. M., Schwabe J. W. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 1999 Dec 15;13(24):3209–3216. doi: 10.1101/gad.13.24.3209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nolte R. T., Wisely G. B., Westin S., Cobb J. E., Lambert M. H., Kurokawa R., Rosenfeld M. G., Willson T. M., Glass C. K., Milburn M. V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 1998 Sep 10;395(6698):137–143. doi: 10.1038/25931. [DOI] [PubMed] [Google Scholar]
  32. Nordhoff E., Krogsdam A. M., Jorgensen H. F., Kallipolitis B. H., Clark B. F., Roepstorff P., Kristiansen K. Rapid identification of DNA-binding proteins by mass spectrometry. Nat Biotechnol. 1999 Sep;17(9):884–888. doi: 10.1038/12873. [DOI] [PubMed] [Google Scholar]
  33. Oberfield J. L., Collins J. L., Holmes C. P., Goreham D. M., Cooper J. P., Cobb J. E., Lenhard J. M., Hull-Ryde E. A., Mohr C. P., Blanchard S. G. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6102–6106. doi: 10.1073/pnas.96.11.6102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Oliver W. R., Jr, Shenk J. L., Snaith M. R., Russell C. S., Plunket K. D., Bodkin N. L., Lewis M. C., Winegar D. A., Sznaidman M. L., Lambert M. H. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A. 2001 Apr 17;98(9):5306–5311. doi: 10.1073/pnas.091021198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Park E. J., Schroen D. J., Yang M., Li H., Li L., Chen J. D. SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3519–3524. doi: 10.1073/pnas.96.7.3519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Perissi V., Staszewski L. M., McInerney E. M., Kurokawa R., Krones A., Rose D. W., Lambert M. H., Milburn M. V., Glass C. K., Rosenfeld M. G. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 1999 Dec 15;13(24):3198–3208. doi: 10.1101/gad.13.24.3198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pissios P., Tzameli I., Kushner P., Moore D. D. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding. Mol Cell. 2000 Aug;6(2):245–253. doi: 10.1016/s1097-2765(00)00026-5. [DOI] [PubMed] [Google Scholar]
  38. Reginato M. J., Bailey S. T., Krakow S. L., Minami C., Ishii S., Tanaka H., Lazar M. A. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties. J Biol Chem. 1998 Dec 4;273(49):32679–32684. doi: 10.1074/jbc.273.49.32679. [DOI] [PubMed] [Google Scholar]
  39. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998 Jan 1;391(6662):79–82. doi: 10.1038/34178. [DOI] [PubMed] [Google Scholar]
  40. Shibata H., Nawaz Z., Tsai S. Y., O'Malley B. W., Tsai M. J. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol Endocrinol. 1997 Jun;11(6):714–724. doi: 10.1210/mend.11.6.0002. [DOI] [PubMed] [Google Scholar]
  41. Shibata H., Spencer T. E., Oñate S. A., Jenster G., Tsai S. Y., Tsai M. J., O'Malley B. W. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res. 1997;52:141–165. [PubMed] [Google Scholar]
  42. Uppenberg J., Svensson C., Jaki M., Bertilsson G., Jendeberg L., Berkenstam A. Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma. J Biol Chem. 1998 Nov 20;273(47):31108–31112. doi: 10.1074/jbc.273.47.31108. [DOI] [PubMed] [Google Scholar]
  43. Webb P., Anderson C. M., Valentine C., Nguyen P., Marimuthu A., West B. L., Baxter J. D., Kushner P. J. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol. 2000 Dec;14(12):1976–1985. doi: 10.1210/mend.14.12.0566. [DOI] [PubMed] [Google Scholar]
  44. Westergaard M., Henningsen J., Svendsen M. L., Johansen C., Jensen U. B., Schrøder H. D., Kratchmarova I., Berge R. K., Iversen L., Bolund L. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol. 2001 May;116(5):702–712. doi: 10.1046/j.1523-1747.2001.01329.x. [DOI] [PubMed] [Google Scholar]
  45. Xing G., Zhang L., Zhang L., Heynen T., Yoshikawa T., Smith M., Weiss S., Detera-Wadleigh S. Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem Biophys Res Commun. 1995 Dec 26;217(3):1015–1025. doi: 10.1006/bbrc.1995.2871. [DOI] [PubMed] [Google Scholar]
  46. Xu H. E., Lambert M. H., Montana V. G., Parks D. J., Blanchard S. G., Brown P. J., Sternbach D. D., Lehmann J. M., Wisely G. B., Willson T. M. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell. 1999 Mar;3(3):397–403. doi: 10.1016/s1097-2765(00)80467-0. [DOI] [PubMed] [Google Scholar]
  47. Xu H. E., Lambert M. H., Montana V. G., Plunket K. D., Moore L. B., Collins J. L., Oplinger J. A., Kliewer S. A., Gampe R. T., Jr, McKee D. D. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A. 2001 Nov 6;98(24):13919–13924. doi: 10.1073/pnas.241410198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Xu L., Glass C. K., Rosenfeld M. G. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev. 1999 Apr;9(2):140–147. doi: 10.1016/S0959-437X(99)80021-5. [DOI] [PubMed] [Google Scholar]
  49. Zamir I., Harding H. P., Atkins G. B., Hörlein A., Glass C. K., Rosenfeld M. G., Lazar M. A. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol. 1996 Oct;16(10):5458–5465. doi: 10.1128/mcb.16.10.5458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zamir I., Zhang J., Lazar M. A. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 1997 Apr 1;11(7):835–846. doi: 10.1101/gad.11.7.835. [DOI] [PubMed] [Google Scholar]
  51. Zhang J., Hu X., Lazar M. A. A novel role for helix 12 of retinoid X receptor in regulating repression. Mol Cell Biol. 1999 Sep;19(9):6448–6457. doi: 10.1128/mcb.19.9.6448. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES